Additional mutations affect consensus cancer genes (CDKN2A, IDH2, TP53) as well as tumor suppressors previously identified in cutaneous T cell lymphoma (TNFAIP3, FAS, PDCD1). Here, IDH2 is linked to primary cutaneous T-cell non-Hodgkin lymphoma.